First mover in psychedelics - EMD's clinics are at capacity, major payers are onboard, and the data shows the treatment works
ASX:EMD
|
13 min
Australia became the first country in the world to legalise the medical use of MDMA and psilocybin for mental health conditions in 2023. Since then, our investment Emyria (ASX: EMD) has positioned itself as a first mover, building out a network of private clinics providing psychedelic‑assisted treatments for mental health. $44M capped EMD is positioning itself as a first-mover and specialist operator in a small (but very fast growing) market for psychedelic mental health care.